Fisher Wallace Neurostimulation & Depression Study

Running, not enrolling · Not applicable · Has a placebo group

Conditions studied: Major Depressive Disorder

In brief

Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.

Key facts

Study ID

NCT04541563

Run by

ProofPilot

People needed

175

Starts

2020-08-24

Expected to finish

2021-11-30

Last updated by the study team

2021-02-11

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age greater than or equal to 21
• US resident
• Can receive packages to their home via UPS/Fedex/USPS
• Major Depressive Disorder
• PHQ-8 Score greater than 10 (show some signs of mild to moderate depression)
• PHQ-8 Score less than 20 (given remote study serious depressed should be excluded)
• Read/write English
• have not contemplated suicide in the past year
• not been institutionalized for mental health issues.
• not currently experiencing problems with alcohol or drug abuse
• can commit to not drinking alcohol 4 hours before bedtime for the duration of the study
• can commit to two (2) 20 minute sessions per day for 8 weeks
• has not used a brain stimulation treatment in one year
• no suspected or known history of heart disease
• no pacemaker
• not under medical supervision for other serious medical condition
• not taking opioids
• is a resident of states in which we have licensed medical professionals

Where it is running

• ProofPilot (Remote Virtual Trial) — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.